Faunce TA[au] - Search Results

Year	Number of Results
1991	1
1997	1
1998	2
1999	1
2003	3
2004	2
2005	8
2006	3
2007	6
2008	3
2009	5
2010	2
2011	2
2012	1
2013	2
2019	1
2024	0

1

NCDs and the WHO Essential Medicines Lists: children need universal health coverage too.

Gray NJ, Chanoine JP, Farmer MY, Jarvis JD, Armstrong K, Barr RD, Faunce TA, Lashley PM, Ndikumwenayo F, Hauerslev M, Karekezi CW, Klein JD; NCD Child Task Force on Essential Medicines and Equipment. Gray NJ, et al. Among authors: faunce ta. Lancet Child Adolesc Health. 2019 Nov;3(11):756-757. doi: 10.1016/S2352-4642(19)30294-9. Epub 2019 Sep 16. Lancet Child Adolesc Health. 2019. PMID: 31537467 Review. No abstract available.

2

A methodological framework of preparing economic evidence for selection of medicines in the Chinese setting.

Sun X, Faunce TA. Sun X, et al. Among authors: faunce ta. J Evid Based Med. 2010 Aug;3(3):156-61. doi: 10.1111/j.1756-5391.2010.01087.x. J Evid Based Med. 2010. PMID: 21349060 Review.

3

Cutting for stone.

Faunce TA. Faunce TA. Med Humanit. 2009 Dec;35(2):123-4. doi: 10.1136/jmh.2009.002519. Med Humanit. 2009. PMID: 23674714 No abstract available.

4

'Atypical' antidepressants in overdose: clinical considerations with respect to safety.

Buckley NA, Faunce TA. Buckley NA, et al. Among authors: faunce ta. Drug Saf. 2003;26(8):539-51. doi: 10.2165/00002018-200326080-00002. Drug Saf. 2003. PMID: 12825968 Review.

5

Nanotechnology in global medicine and human biosecurity: private interests, policy dilemmas, and the calibration of public health law.

Faunce TA. Faunce TA. J Law Med Ethics. 2007 Winter;35(4):629-42, 512. doi: 10.1111/j.1748-720X.2007.00186.x. J Law Med Ethics. 2007. PMID: 18076514 Review.

6

Integrated research into the nanoparticle-protein corona: a new focus for safe, sustainable and equitable development of nanomedicines.

Faunce TA, White J, Matthaei KI. Faunce TA, et al. Nanomedicine (Lond). 2008 Dec;3(6):859-66. doi: 10.2217/17435889.3.6.859. Nanomedicine (Lond). 2008. PMID: 19025459 Review.

7

Toxicological and public good considerations for the regulation of nanomaterial-containing medical products.

Faunce TA. Faunce TA. Expert Opin Drug Saf. 2008 Mar;7(2):103-6. doi: 10.1517/14740338.7.2.103. Expert Opin Drug Saf. 2008. PMID: 18324873

8

Safety of nanoparticles in sunscreens.

Faunce TA. Faunce TA. Med J Aust. 2009 Apr 20;190(8):463. doi: 10.5694/j.1326-5377.2009.tb02514.x. Med J Aust. 2009. PMID: 19374630 No abstract available.

9

Melatonin supplementation from early morning auto-urine drinking.

Mills MH, Faunce TA. Mills MH, et al. Among authors: faunce ta. Med Hypotheses. 1991 Nov;36(3):195-9. doi: 10.1016/0306-9877(91)90129-m. Med Hypotheses. 1991. PMID: 1787809

10

Normative role for medical humanities.

Faunce TA. Faunce TA. Lancet. 2003 Nov 29;362(9398):1859. doi: 10.1016/S0140-6736(03)14919-7. Lancet. 2003. PMID: 14654339 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

43 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Results by year